Cardiac rehabilitation participant with sickle cell trait and statin-related hepatotoxicity: A case report

Journal of Cardiopulmonary Rehabilitation and Prevention

Volumn 32, Issue 4, 2012, Pages 182-186

  Kato, John David ^a   Wang, Cheng Tao ^a  

^a Trillium Health Centre   (Canada)

Author keywords

Cardiac rehabilitation; Hepatotoxicity; Sickle cell trait; Statin

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BISOPROLOL; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LIVER ENZYME; NIFEDIPINE; PANTOPRAZOLE; RAMIPRIL; ROSUVASTATIN; VALSARTAN;

ADULT; AEROBIC EXERCISE; ARTICLE; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAPHY; HEART INFARCTION; HEART REHABILITATION; HUMAN; HYPERLIPIDEMIA; LABORATORY TEST; LIPID BLOOD LEVEL; LIVER TOXICITY; MALE; PRIORITY JOURNAL; SICKLE CELL TRAIT; SIDE EFFECT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN; TREATMENT DURATION;

ANTICHOLESTEREMIC AGENTS; CHEST PAIN; DRUG-INDUCED LIVER INJURY; DYSPNEA; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SICKLE CELL TRAIT;

EID: 84866027906     PISSN: 19327501     EISSN: 1932751X     Source Type: Journal    
DOI: 10.1097/HCR.0b013e318255a382     Document Type: Article

References (15)

1. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.
2. American College of Sports Medicine. ACSM's Guidelines for exercise Testing and Prescription. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2010.
3. Thogmartin JR, Wilson CI, Palma NA, Ignacio SS, Shuman MJ, Flannagan LM. Sickle cell trait-associated deaths: A case series with a review of the literature. J Forensic Sci. 2011;56:1352-1360.
4. Genest J, McPhereson R, Frohlich J, et al; 2009 Canadian Cardiovascular Society. Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol. 2009;25:567-579.
5. Balady GJ, Arena R, Sietsema K, et al. Clinician's guide to cardiopulmonary exercise testing in adults: A scientific statement from the American Heart Association. Circulation. 2010;122:191-225.
6. Charles EC, Olson KL, Sandhoff BG, McClure DL, Merenich JA. Evaluation of cases of severe statin-related transaminitis w ithin a large health maintenance organization. Am J Med. 2005;118: 618-624.
7. Canadian Pharmacists Association. http://www. e-therapeutics. ca-cps.showMonograph.action. Accessed June 3, 2011.
8. Tsaras G, Owusu-Ansah A, Boateng FO, Amoateng-Adjepong Y. Complications associated with sickle cell trait: A brief narrative review. Am J Med. 2009;122:507-512.
9. Diggs LW. The sickle cell trait in relation to the training and assignment of duties in the armed forces: IV. Considerations and recommendations. Aviat Space Environ Med. 1984;55:487-492.
10. Anzalone ML, Green V, Buja M, Sanchez LA, Harrykissoon R, Eichner ER. Sickle cell trait and fatal rhabdomyolysis in football training: A case study. Med Sci Sport Exerc. 2010;42:3-7.
11. Ashcroft MT, Desai P. Mortality and morbidity in Jamaican adults with sickle cell trait and with normal hemoglobin followed up to twelve years. Lancet. 1976;2(7989):784-786.
12. National Athletic Trainers' Association. Consensus statement: sickle cell trait and the athlete. http://www. nata.org-sites-defalt-files- SickleCellTraitAndTheAthlete.pdf. Accessed June 3, 2011.
13. Gardner AW, Afaq A. Management of lower extremity peripheral arterial disease. J Cardiopulm Rehabil Prev. 2008;28:349-357.
14. Connes P, Reid H, Hardy-Dessources MD, Morrison E, Hue O. Physiological responses of sickle cell trait carriers during exercise. Sport Med. 2008;38:931-946.
15. Sherry P. Sickle cell trait and rhabdomyolysis: case report and review of the literature. Mil Med. 1990;155:59-61.